Nursing2023 Drug Handbook
Seiten
2022
|
Forty-Third, North American Edition
Wolters Kluwer Health (Verlag)
978-1-9751-8336-3 (ISBN)
Wolters Kluwer Health (Verlag)
978-1-9751-8336-3 (ISBN)
- Titel erscheint in neuer Auflage
- Artikel merken
Zu diesem Artikel existiert eine Nachauflage
Selected as a Doody's Core Title for 2022!
Prevent medication errors and provide optimal patient care with the latest expert advice from the new edition of the best-selling nursing drug guide. Nursing2023 Drug Handbook® delivers evidence-based, nursing-focused drug monographs for nearly 3700 generic, brand-name, and combination drugs. With a tabbed, alphabetical organization and a “New Drugs” section, NDH2023 makes it easy to check drug facts on the spot.
All new: 27 monographs of newly-FDA-approved drugs are listed together for easy review.
Thoroughly revised with the latest information: 3,691 drug monographs provide dosages, indications, boxed warnings, genetic-related information, adverse reactions, clinical alerts, and patient teaching information. The Guide to Reading Drug Monographs explains and illustrates each section of a monograph.
Pill guide insert: Full-color photos distinguish 439 commonly prescribed tablets and capsules
Continually updated: Monthly updates on Lippincott® NursingCenter® deliver the latest FDA information.
Nearly 30 appendices cover topics such as serotonin syndrome, pregnancy risk categories, and understanding biosimilar drugs.
Four introductory chapters examine drug actions, interactions, and reactions; drug therapy across the lifespan; safe drug administration; and therapeutic drug classifications.
Prevent medication errors and provide optimal patient care with the latest expert advice from the new edition of the best-selling nursing drug guide. Nursing2023 Drug Handbook® delivers evidence-based, nursing-focused drug monographs for nearly 3700 generic, brand-name, and combination drugs. With a tabbed, alphabetical organization and a “New Drugs” section, NDH2023 makes it easy to check drug facts on the spot.
All new: 27 monographs of newly-FDA-approved drugs are listed together for easy review.
Thoroughly revised with the latest information: 3,691 drug monographs provide dosages, indications, boxed warnings, genetic-related information, adverse reactions, clinical alerts, and patient teaching information. The Guide to Reading Drug Monographs explains and illustrates each section of a monograph.
Pill guide insert: Full-color photos distinguish 439 commonly prescribed tablets and capsules
Continually updated: Monthly updates on Lippincott® NursingCenter® deliver the latest FDA information.
Nearly 30 appendices cover topics such as serotonin syndrome, pregnancy risk categories, and understanding biosimilar drugs.
Four introductory chapters examine drug actions, interactions, and reactions; drug therapy across the lifespan; safe drug administration; and therapeutic drug classifications.
Erscheinungsdatum | 04.06.2022 |
---|---|
Sprache | englisch |
Maße | 127 x 203 mm |
Themenwelt | Medizin / Pharmazie ► Pflege ► Ausbildung / Prüfung |
ISBN-10 | 1-9751-8336-3 / 1975183363 |
ISBN-13 | 978-1-9751-8336-3 / 9781975183363 |
Zustand | Neuware |
Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Buch | Spiralbindung (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 26,60
Buch | Spiralbindung (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 48,80